Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Effect of reporting bias on meta-analyses of drug trials: reanalysis of meta-analyses

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Prospective risk of stillbirth and neonatal complications in twin pregnancies: systematic review and meta-analysis

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Re: Restoring Study 329: efficacy and harms of paroxetine and imipramine in treatment of major depression in adolescence

    Research output: Contribution to journalComment/debateResearchpeer-review

  3. "Adaptive pathways" to drug authorisation: adapting to industry?

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Antidepressants are addictive and increase the risk of relapse

    Research output: Contribution to journalLetterResearchpeer-review

  5. Author's reply to Dubicka and colleagues and Stone

    Research output: Contribution to journalComment/debateResearchpeer-review

View graph of relations
To investigate the effect of including unpublished trial outcome data obtained from the Food and Drug Administration (FDA) on the results of meta-analyses of drug trials.
Original languageEnglish
JournalB M J
Volume344
Pages (from-to)d7202
ISSN0959-8146
Publication statusPublished - 2012

    Research areas

  • Clinical Trials as Topic, Drug Approval, Drug Evaluation, Meta-Analysis as Topic, Publication Bias, Review Literature as Topic, United States, United States Food and Drug Administration

ID: 36753101